Close Menu

NEW YORK – Ginkgo Bioworks and Berkeley Lights said today that they have inked a $150 million deal to incorporate Berkeley Lights' Beacon optofluidic platform into Ginkgo's automated genetic engineering foundries.

Under the multi-year, non-exclusive deal, Boston-based Ginkgo will acquire Beacon platforms from Emeryville, California-based Berkeley Lights and fund the development of workflows to use them in a variety of microbial and mammalian organisms, a Ginkgo spokesperson said in an email.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.

Noel Rose, the "father of autoimmunity," has died at 92, the Washington Post reports.

According to CNN, Legionella was discovered in buildings leased by the Centers for Disease Control and Prevention as they reopened following coronavirus pandemic-related closures.

In PLOS this week: genetic analysis of malaria parasite populations in Southeast Asia, genomic surveillance of yellow fever virus in São Paulo, and more.